4//SEC Filing
Kavanaugh William Michael 4
Accession 0001140361-17-037761
CIK 0001501989other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 12:20 PM ET
Size
8.3 KB
Accession
0001140361-17-037761
Insider Transaction Report
Form 4
Kavanaugh William Michael
CSO, Head Res.&Non-Clin. Dev.
Transactions
- Exercise/Conversion
Common Stok
2017-10-04$4.47/sh+48,368$216,340→ 62,285 total - Sale
Common Stock
2017-10-04$24.34/sh−48,368$1,177,277→ 13,917 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-10-04−48,368→ 48,368 totalExercise: $4.47Exp: 2025-05-06→ Common Stock (48,368 underlying)
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001578767
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 12:20 PM ET
- Size
- 8.3 KB